Literature DB >> 22416601

The correlation of fluid balance changes during cardiopulmonary bypass to mortality in pediatric and congenital heart surgery patients.

Gary Grist1, Carrie Whittaker, Kellie Merrigan, Jason Fenton, Elizabeth Worrall, James O'Brien, Gary Lofland.   

Abstract

Edema acquired during the perioperative period has long been associated with increased mortality. Edema acquired during cardiopulmonary bypass (CPB) may contribute to this mortality. The intent of this retrospective study was to test the premise that edema in the form of a positive fluid balance change (FBC) acquired during CPB correlated to mortality. If so, FBC from the beginning of CPB (baseline; FBC = 0) to the end of CPB may need to be monitored, measured, and controlled on CPB with the same ardor as blood pressure and pH. This retrospective analysis reviewed the FBC of 1540 pediatric and congenital heart surgery patients at the end of CPB. Additions and subtractions of fluid to the combined patient/CPB circuit were routinely quantified during CPB procedures and during periods of modified ultrafiltration (MUF). The primary outcome assessed was mortality during hospitalization. The overall mortality of the 1540 patients was 5.65% from all causes. Eighty percent (n = 1226, mortality = 4.65%) of the patients had a zero or negative FBC immediately after CPB/MUF. Twenty percent (n = 314, mortality = 9.55%) had a positive FBC. Positive FBC patients tended to be in higher risk categories, weighed more, and had longer pump times (p < .05) with an adjusted odds ratio for mortality of 1.73 (1.01-2.96, 95% confidence interval). There is a correlation between edema acquired during CPB and increased mortality in pediatric and congenital heart surgery patients. The potential exists for the perfusionist to optimize the fluid balance changes while on CPB to reduce mortality rates.

Entities:  

Mesh:

Year:  2011        PMID: 22416601      PMCID: PMC4557424     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  28 in total

1.  Risk adjustment for congenital heart surgery: the RACHS-1 method.

Authors:  Kathy J Jenkins
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2004

Review 2.  Circulatory shock in children: an overview.

Authors:  Christine A McKiernan; Stephen A Lieberman
Journal:  Pediatr Rev       Date:  2005-12

3.  How does higher ultrafiltration within the conventional clinical range impact the volume status of hemodialysis patients?

Authors:  M Yashiro; T Kamata; H Segawa; T Murakami; Y Kadoya; E Muso
Journal:  Blood Purif       Date:  2009-02-14       Impact factor: 2.614

Review 4.  The 'third space'--fact or fiction?

Authors:  Matthias Jacob; Daniel Chappell; Markus Rehm
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2009-06

5.  Bicarbonate-buffered ultrafiltration during pediatric cardiac surgery prevents electrolyte and acid-base balance disturbances.

Authors:  W A Osthaus; H Görler; J Sievers; N Rahe-Meyer; J Optenhöfel; T Breymann; G Theilmeier; R Suempelmann
Journal:  Perfusion       Date:  2009-01       Impact factor: 1.972

6.  [Congestive heart failure in childhood. An epidemiologic study].

Authors:  Claudia Sommers; Bert H P Nagel; Ulrich Neudorf; Achim A Schmaltz
Journal:  Herz       Date:  2005-11       Impact factor: 1.443

7.  Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Stefanie Hammer; Alexandra T Fuchs; Carsten Rinker; Sabine Daebritz; Rainer Kozlik-Feldmann; Heinrich Netz
Journal:  Acta Cardiol       Date:  2004-12       Impact factor: 1.718

8.  Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.

Authors:  K Bando; M W Turrentine; T G Sharp; Y Sekine; T X Aufiero; K Sun; E Sekine; J W Brown
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

Review 9.  Tetralogy of fallot: yesterday and today.

Authors:  Joanne P Starr
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

10.  Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type.

Authors:  Pascal A Berdat; Evelyne Eichenberger; Julia Ebell; Jean-Pierre Pfammatter; Mladen Pavlovic; Claudia Zobrist; Erich Gygax; Urs Nydegger; Thierry Carrel
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

View more
  6 in total

1.  Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery.

Authors:  Kenneth E Mah; Shiying Hao; Scott M Sutherland; David M Kwiatkowski; David M Axelrod; Christopher S Almond; Catherine D Krawczeski; Andrew Y Shin
Journal:  Pediatr Nephrol       Date:  2017-11-11       Impact factor: 3.714

2.  Association of postoperative fluid overload with adverse outcomes after congenital heart surgery: a systematic review and dose-response meta-analysis.

Authors:  Ioannis Bellos; Dimitrios C Iliopoulos; Despina N Perrea
Journal:  Pediatr Nephrol       Date:  2020-02-10       Impact factor: 3.714

Review 3.  Evaluation of Hypervolemia in Children.

Authors:  Matjaž Kopač
Journal:  J Pediatr Intensive Care       Date:  2020-07-30

Review 4.  American Society of ExtraCorporeal Technology: Development of Standards and Guidelines for Pediatric and Congenital Perfusion Practice (2019).

Authors:  Molly E Oldeen; Ronald E Angona; Ashley Hodge; Tom Klein
Journal:  J Extra Corpor Technol       Date:  2020-12

Review 5.  Fluid Overload in Critically Ill Children.

Authors:  Rupesh Raina; Sidharth Kumar Sethi; Nikita Wadhwani; Meghana Vemuganti; Vinod Krishnappa; Shyam B Bansal
Journal:  Front Pediatr       Date:  2018-10-29       Impact factor: 3.418

6.  Altered kinetics of circulating progenitor cells in cardiopulmonary bypass (CPB) associated vasoplegic patients: A pilot study.

Authors:  Sanhita Nandi; Uma Rani Potunuru; Chandrani Kumari; Abel Arul Nathan; Jayashree Gopal; Gautam I Menon; Rahul Siddharthan; Madhulika Dixit; Paul Ramesh Thangaraj
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.